Hervelous
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Hervelous, covering 2022-12-13 to 2022-12-13. Get the full timeline:
Most recent: EMA Application withdrawn: Hervelous (trastuzumab) — Prestige Biopharma Belgium